Skip to main content
. 2017 Dec 18;29(3):694–699. doi: 10.1093/annonc/mdx795

Figure 3.

Figure 3.

Illustration of trial conduct. Each circle represents a cohort of three patients, whose toxicity and efficacy outcomes are indicated by different colors. The EffTox design selects dose level 3 as the optimal dose. In contrast, the 3 + 3 design would select dose level 2 as the MTD, which shows little evidence of efficacy.